Abstract
Third-year pharmacy students (n = 88) participated in an anti-stigma intervention program consisting of presentations, videos, discussion and active-learning exercises. Willingness to counsel (WTC) people with mental illness (MI) was evaluated using immediate pre and post-tests comparing diabetes, depression and schizophrenia. At pre-test, WTC diabetes was highest (higher = increased WTC) while schizophrenia was the lowest. There were no statistically significant differences between pre/post-test WTC for diabetes and depression, while schizophrenia WTC increased significantly (p < 0.05). At post-test, diabetes WTC was significantly higher than depression and schizophrenia (p < 0.0001). Regression results for WTC depression showed that comfortability and gender were significant (p < 0.05) predictors. Regression results for WTC schizophrenia showed that comfortability was a significant (p < 0.05) predictor. As highly accessible healthcare providers, pharmacists have the potential to positively impact healthcare, but this depends on WTC. Colleges of pharmacy may consider instituting policies that support experiential education involving counseling people living with MI, as this may increase comfortability.
Similar content being viewed by others
References
Abdullah, T., & Brown, T. L. (2011). Mental illness stigma and ethnocultural beliefs, values, and norms: An integrative review. Clinical Psychology Review, 31(6), 934–948.
Ajzen, I. (1985). From intentions to actions: A theory of planned behavior. Berlin: Springer.
Albarracin, D., Johnson, B. T., Fishbein, M., & Muellerleile, P. A. (2001). Theories of reasoned action and planned behavior as models of condom use: A meta-analysis. Psychological Bulletin, 127(1), 142.
Angermeyer, M. C., & Matschinger, H. (2003). Public beliefs about schizophrenia and depression: Similarities and differences. Social Psychiatry and Psychiatric Epidemiology, 38(9), 526–534.
Bamgbade, B. A., Ford, K. H., & Barner, J. C. (2016). Impact of a mental illness stigma awareness intervention on pharmacy student attitudes and knowledge. American Journal of Pharmaceutical Education, 80(5), 80.
Bednall, T. C., Bove, L. L., Cheetham, A., & Murray, A. L. (2013). A systematic review and meta-analysis of antecedents of blood donation behavior and intentions. Social Science and Medicine, 96, 86–94.
Bell, J., Aaltonen, S., Airaksinen, M., Volmer, D., Gharat, M., Muceniece, R., et al. (2009). Determinants of mental health stigma among pharmacy students in Australia, Belgium, Estonia, Finland, India and Latvia. International Journal of Social Psychiatry, 56(1), 3–14.
Bell, J. S., Aaltonen, S. E., Bronstein, E., Desplenter, F. A., Foulon, V., Vitola, A., et al. (2008). Attitudes of pharmacy students toward people with mental disorders, a six country study. Pharmacy World and Science, 30(5), 595–599.
Bell, J. S., Johns, R., & Chen, T. F. (2006a). Pharmacy students’ and graduates’ attitudes towards people with schizophrenia and severe depression. American Journal of Pharmaceutical Education, 70(4), 77.
Bell, J. S., Johns, R., Rose, G., & Chen, T. F. (2006b). A comparative study of consumer participation in mental health pharmacy education. Annals of Pharmacotherapy, 40(10), 1759–1765.
Bell, J. S., Whitehead, P., Aslani, P., Sacker, S., & Chen, T. F. (2006c). Design and implementation of an educational partnership between community pharmacists and consumer educators in mental health care. American Journal of Pharmaceutical Education, 70(2), 28.
Bell, S., McLachlan, A. J., Aslani, P., Whitehead, P., & Chen, T. F. (2005). Community pharmacy services to optimise the use of medications for mental illness: A systematic review. Australia and New Zealand Health Policy, 2(1), 29.
Black, E., Murphy, A. L., & Gardner, D. M. (2009). Community pharmacist services for people with mental illnesses: preferences, satisfaction, and stigma. Psychiatric Services, 60(8), 1123–1127.
Buhler, A. V., & Buhler, R. M. (2008). Peer-level patient presenters decrease pharmacy students’ social distance from patients with schizophrenia and clinical depression. American Journal of Pharmaceutical Education, 72(5), 106.
Cannon-Breland, M. L., Westrick, S. C., Kavookjian, J., Berger, B. A., Shannon, D. M., & Lorenz, R. A. (2013). Pharmacist self-reported antidepressant medication counseling. Journal of the American Pharmacists Association, 53(4), 390–399.
Connery, H., & Davidson, K. M. (2006). A survey of attitudes to depression in the general public: A comparison of age and gender differences. Journal of Mental Health, 15(2), 179–189.
Corrigan, P. W., Green, A., Lundin, R., Kubiak, M. A., & Penn, D. L. (2001). Familiarity with and social distance from people who have serious mental illness. Psychiatric Services, 52(7), 953–958.
Crisp, A. H., Gelder, M. G., Rix, S., Meltzer, H. I., & Rowlands, O. J. (2000). Stigmatisation of people with mental illnesses. British Journal of Psychiatry, 177(1), 4–7.
Fancher, T. L., Lee, D., Cheng, J. K. Y., Yang, M. S., & Yang, L. (2014). Interventions to improve adherence to psychotropic medication in clients of Asian descent: A systematic review. Asian American Journal of Psychology, 5(1), 22.
Finley, P. R., Crismon, M. L., & Rush, A. J. (2003). Evaluating the impact of pharmacists in mental health: a systematic review. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 23(12), 1634–1644.
Gabbidon, J., Clement, S., van Nieuwenhuizen, A., Kassam, A., Brohan, E., Norman, I., et al. (2012). Mental Illness: Clinicians’ Attitudes (MICA) Scale—psychometric properties of a version for healthcare students and professionals. Psychiatry Research, 206(1), 81–87.
Hagger, M. S., Chatzisarantis, N. L. D., & Biddle, S. J. H. (2002). A meta-analytic review of the theories of reasoned action and planned behavior in physical activity: predictive validity and the contribution of additional variables. Journal of Sport and Exercise Psychology, 24(1), 3–32.
Hasin, D. S., Goodwin, R. D., Stinson, F. S., & Grant, B. F. (2005). Epidemiology of major depressive disorder: Results from the national epidemiologic survey on alcoholism and related conditions. Archives of General Psychiatry, 62(10), 1097–1106. doi:10.1001/archpsyc.62.10.1097.
Hoch, M. A., Ott, C. A., Hudmon, K. S., & Plake, K. S. (2011). Attitudes of individuals with schizophrenia toward pharmacists. Journal of the American Pharmacists Association: JAPhA, 52(6), 783–786.
Jorm, A. F., Korten, A. E., Jacomb, P. A., Christensen, H., & Henderson, S. (1999). Attitudes towards people with a mental disorder: A survey of the Australian public and health professionals. Australian and New Zealand Journal of Psychiatry, 33(1), 77–83. doi:10.1046/j.1440-1614.1999.00513.x.
Julius, R. J., Novitsky, M. A. Jr., & Dubin, W. R. (2009). Medication adherence: A review of the literature and implications for clinical practice. Journal of Psychiatric Practice, 15(1), 34–44.
Kassam, A., Papish, A., Modgill, G., & Patten, S. (2012). The development and psychometric properties of a new scale to measure mental illness related stigma by health care providers: The Opening Minds Scale for Health Care Providers (OMS-HC). BMC Psychiatry, 12(1), 62.
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62(6), 593–602. doi:10.1001/archpsyc.62.6.593.
Kessler, R. C., McGonagle, K. A., Swartz, M., Blazer, D. G., & Nelson, C. B. (1993). Sex and depression in the National Comorbidity Survey I: Lifetime prevalence, chronicity and recurrence. Journal of Affective Disorders, 29(2), 85–96.
Krueger, J. L., & Hermansen-Kobulnicky, C. J. (2010). Patient perspective of medication information desired and barriers to asking pharmacists questions. Journal of the American Pharmacists Association: JAPhA, 51(4), 510–519.
Lauber, C., Nordt, C., Falcato, L., & Rössler, W. (2004). Factors influencing social distance toward people with mental illness. Community Mental Health Journal, 40(3), 265–274.
Liekens, S., Smits, T., Laekeman, G., & Foulon, V. (2012a). Factors determining social distance toward people with depression among community pharmacists. European Psychiatry, 27(7), 528–535.
Liekens, S., Smits, T., Laekeman, G., & Foulon, V. (2012b). Pharmaceutical care for people with depression: Belgian pharmacists’ attitudes and perceived barriers. International Journal of Clinical Pharmacy, 34(3), 452–459.
Liekens, S., Smits, T., Laekeman, G., & Foulon, V. (2013). A depression training session with consumer educators to reduce stigmatizing views and improve pharmacists’ depression care attitudes and practices. American Journal of Pharmaceutical Education, 77(6), 120.
Liekens, S., Vandael, E., Roter, D., Larson, S., Smits, T., Laekeman, G., et al. (2014). Impact of training on pharmacists’ counseling of patients starting antidepressant therapy. Patient Education and Counseling, 94(1), 110–115.
Link, B. G., Cullen, F. T., Frank, J., & Wozniak, J. F. (1987). The social rejection of former mental patients: understanding why labels matter. American Journal of Sociology, 92(6), 1461–1500.
Link, B. G., & Phelan, J. C. (2001). Conceptualizing Stigma. Annual Review of Sociology, 27, 363–385. doi:10.1146/annurev.soc.27.1.363.
Mojtabai, R., & Olfson, M. (2014). National trends in long-term use of antidepressant medications: Results from the US National Health and Nutrition Examination Survey. Journal of Clinical Psychiatry, 75(2), 169–177.
Nguyen, E., Chen, T. F., & O’Reilly, C. L. (2012). Evaluating the impact of direct and indirect contact on the mental health stigma of pharmacy students. Social Psychiatry and Psychiatric Epidemiology, 47(7), 1087–1098.
O’Donnell, D. C., Brown, C. M., & Dastani, H. B. (2005). Barriers to counseling patients with obesity: A study of Texas community pharmacists. Journal of the American Pharmacists Association: JAPhA, 46(4), 465–471.
O’Loughlin, J., Masson, P., Déry, V., & Fagnan, D. (1999). The role of community pharmacists in health education and disease prevention: A survey of their interests and needs in relation to cardiovascular disease. Preventive Medicine, 28(3), 324–331.
O’Reilly, C. L., Bell, J. S., & Chen, T. F. (2010). Consumer-led mental health education for pharmacy students. American Journal of Pharmaceutical Education, 74(9), 167.
O’Reilly, C. L., Bell, J. S., Kelly, P. J., & Chen, T. F. (2011). Impact of mental health first aid training on pharmacy students’ knowledge, attitudes and self-reported behaviour: a controlled trial. Australian and New Zealand Journal of Psychiatry, 45(7), 549–557. doi:10.3109/00048674.2011.585454.
O’Reilly, C. L., Bell, J. S., Kelly, P. J., & Chen, T. F. (2013). Exploring the relationship between mental health stigma, knowledge and provision of pharmacy services for consumers with schizophrenia. Research in Social and Administrative Pharmacy, 11(3), e101–e109.
O’Reilly, C. L., Simon Bell, J., & Chen, T. F. (2010). Pharmacists’ beliefs about treatments and outcomes of mental disorders: A mental health literacy survey. Australian and New Zealand Journal of Psychiatry, 44(12), 1089–1096.
Olfson, M., Marcus, S. C., Druss, B., Elinson, L., Tanielian, T., & Pincus, H. (2002). National trends in the outpatient treatment of depression. Journal of the American Medical Association, 287(2), 203–209. doi:10.1001/jama.287.2.203.
Patten, S. B., Remillard, A., Phillips, L., Modgill, G., Szeto, A. C., Kassam, A., et al. (2012). Effectiveness of contact-based education for reducing mental illness-related stigma in pharmacy students. BMC Medical Education, 12(1), 120.
Penn, D. L., Guynan, K., Daily, T., Spaulding, W. D., Garbin, C. P., & Sullivan, M. (1994). Dispelling the stigma of schizophrenia: what sort of information is best? Schizophrenia Bulletin, 20(3), 567–578.
Phokeo, V., Sproule, B., & Raman-Wilms, L. (2004). Community pharmacists’ attitudes toward and professional interactions with users of psychiatric medication. Psychiatric Services, 55(12), 1434–1436.
Rickles, N. M., Dube, G. L., McCarter, A., & Olshan, J. S. (2010). Relationship between attitudes toward mental illness and provision of pharmacy services. Journal of the American Pharmacists Association: JAPhA, 50(6), 704.
Rubio-Valera, M., Serrano-Blanco, A., Magdalena-Belío, J., Fernández, A., García-Campayo, J., Pujol, M. M., et al. (2011). Effectiveness of pharmacist care in the improvement of adherence to antidepressants: A systematic review and meta-analysis. Annals of Pharmacotherapy, 45(1), 39–48.
Scheerder, G., De Coster, I., & Van Audenhove, C. (2008). Pharmacists’ role in depression care: A survey of attitudes, current practices, and barriers. Psychiatric Services, 59(10), 1155–1160.
Sheppard, B. H., Hartwick, J., & Warshaw, P. R. (1988). The theory of reasoned action: A meta-analysis of past research with recommendations for modifications and future research. Journal of Consumer Research, 15(3), 325–343.
Siracuse, M. V., Schondelmeyer, S. W., Hadsall, R. S., & Schommer, J. C. (2008). Third-year pharmacy students’ work experience and attitudes and perceptions of the pharmacy profession. American Journal of Pharmaceutical Education, 72(3), 50.
Smith, S. R., Golin, C. E., & Reif, S. (2004). Influence of time stress and other variables on counseling by pharmacists about antiretroviral medications. American Journal of Health-System Pharmacy, 61(11), 1120–1129.
Stern, T. A., Rosenbaum, J. F., Fava, M., Biederman, J., & Rauch, S. L. (2008). Massachusetts general hospital comprehensive clinical psychiatry (1st ed.). UK: Elsevier Health Sciences.
Svarstad, B. L., Bultman, D. C., & Mount, J. K. (2003). Patient counseling provided in community pharmacies: Effects of state regulation, pharmacist age, and busyness. Journal of the American Pharmacists Association: JAPhA, 44(1), 22–29.
Velligan, D. I., Weiden, P. J., Sajatovic, M., Scott, J., Carpenter, D., Ross, R., et al. (2009). The expert consensus guideline series: Adherence problems in patients with serious and persistent mental illness. Journal of Clinical Psychiatry, 70(Suppl 4), 1–46.
Volmer, D., Mäesalu, M., & Bell, J. S. (2008). Pharmacy students’ attitudes toward and professional interactions with people with mental disorders. International Journal of Social Psychiatry, 54(5), 402–413.
Acknowledgements
The authors would like to express our appreciation to Dr. Karen Rascati for providing the opportunity to conduct our intervention in her course. Additionally, we would like to thank the students who participated in this project.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Conflict of interest
The authors have no conflicts of interests to declare.
Human and animal rights
This article does not contain any studies with animals performed by any of the authors.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Bamgbade, B.A., Barner, J.C. & Ford, K.H. Evaluating the Impact of an Anti-stigma Intervention on Pharmacy Students’ Willingness to Counsel People Living with Mental Illness. Community Ment Health J 53, 525–533 (2017). https://doi.org/10.1007/s10597-016-0075-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10597-016-0075-6